IMA
MBOT icon

Investment Management Associates’s Microbot Medical MBOT Stock Holding History

Investment Management Associates’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$75K – 48
2021
Q4 		$75K Hold
10,000
– – 0.03% 51
2021
Q3 		$70K Hold
10,000
– – 0.04% 54
2021
Q2 		$79K Hold
10,000
– – 0.04% 54
2021
Q1 		$85K Buy
+10,000
New +$86K 0.05% 55

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Investment Management Associates's MBOT Position: Q1 2022 in Review

Investment Management Associates sold out of Microbot Medical (MBOT) in Q1 2022, closing a stake of 10,000 shares — an estimated $75K sold.

Investment Management Associates first reported a position in MBOT in Q1 2021 and held it in 4 quarters. The position peaked at $85K in Q1 2021. 27 funds tracked by Wall St. Rank hold MBOT as of Q1 2022.

  • Investment Management Associates reported no remaining Microbot Medical position as of Q1 2022 after selling out during the quarter.
  • Investment Management Associates sold 10,000 Microbot Medical shares in Q1 2022, an estimated $75K.
  • Investment Management Associates first reported a position in Microbot Medical in Q1 2021 and held it in 4 quarters.
  • Investment Management Associates's Microbot Medical position peaked at $85K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2022.

Based on Investment Management Associates's 13F filing for Q1 2022, filed 2 May 2022.